UCB — UCB SA Income Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapHigh Flyer

Annual income statement for UCB SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	5,347	5,777	5,517	5,252	6,152
Cost of Revenue
Gross Profit	3,984	4,339	3,843	3,545	4,400
Selling / General / Administrative Expenses
Research And Development
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	4,376	4,493	4,934	4,648	4,828
Operating Profit	971	1,284	583	604	1,324
Total Net Non Operating Interest Income / Expense
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	880	1,226	511	441	1,163
Provision for Income Taxes
Net Income After Taxes	761	1,056	420	343	1,065
Minority Interest
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	732	1,059	418	343	1,065
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	732	1,058	418	343	1,065
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	4.44	5.59	2.56	1.4	3.23
Dividends per Share